Aurora (ACB): מחיר למכירות

Aurora Cannabis focuses on the export of high-cost medical products and scientific research. Fluctuations in the P/S multiple reflect the dynamics of market valuation relative to revenue, with the latest reading standing at 1.60. Reducing reliance on the Canadian recreational segment in favor of overseas pharmacies strengthens the business. Success is now based on cutting operating expenses and expanding into Australia and Europe.

Geopolitical export restrictions and rising energy costs for greenhouses directly impact the revenue of Aurora Cannabis (ACB), determining the market value of its assets. The current 1.60 metric reflects the ratio of market capitalization to sales volume, allowing investors to assess the premium paid per unit of income and analyze P/S multiple fluctuations to identify a fair entry point into the asset.